CERE
Cerevel Therapeutics Holdings, Inc.
General Counsel Scott Akamine sold $293K of Cerevel Therapeutics Holdings, Inc.
Sold$292,945
$41.42Price
7,072Shares
−49%Stake
What CERE did after the filing
- The stock from Fri, Dec 22 open, $41.37
- +0.4%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Feb 7 close.
Traded Wed, Dec 20. Filed Thu, Dec 21, 8:21 PM ET, after the close. Returns use the Dec 22 open and the Feb 7 close. Not investment advice.